216 results match your criteria Advances in respiratory medicine[Journal]


Amiodarone and diffuse alveolar hemorrhage.

Adv Respir Med 2020 ;88(2):169-171

General Hospital of Corfu, Department of Pulmonary Medicine, Corfu, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0095DOI Listing
January 2020

Curative lobectomy in a patient with pulmonary arteriovenous fistula.

Adv Respir Med 2020 ;88(2):164-165

Department of Sleep Medicine and Metabolic Disorders, Medical University of Łódź, Łódź, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0094DOI Listing
January 2020

Gynecomastia in multi-drug resistant tuberculosis - ethionamide the villain.

Adv Respir Med 2020 ;88(2):162-163

Government Medical College, Patiala, Punjab, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0093DOI Listing
January 2020

An unusual case of right upper zone pneumonic patch.

Adv Respir Med 2020 ;88(2):160-161

All India Institute of Medical Science, Bhubaneswar, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0092DOI Listing
January 2020

Pulmonary oxalosis in pulmonary aspergillosis syndrome.

Adv Respir Med 2020 ;88(2):153-156

Henry Ford Allegiance Internal Medicine Residency Program, Jackson Michigan, United States.

The presence of pulmonary oxalosis in bronchoalveolar lavage (BAL) or biopsied tissue samples is considered pathognomonic for Aspergillus disease etiology. The finding of calcium oxalate crystals in the tissue samples infected with aspergillosis can serve as a vital diagnostic clue. Detection of calcium oxalate crystals is achievable within 24 hours by most hospital microbiology laboratories. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0090DOI Listing
January 2020

Volume-assured pressure support mode plus pirfenidone as resuscitation therapy in patients with exacerbation of idiopathic pulmonary fibrosis.

Adv Respir Med 2020 ;88(2):147-152

Universidad San Francisco de Quito, Quito, Ecuador.

Introduction: Treatment among advanced stage idiopathic pulmonary fibrosis is quite challenging, especially considering that no major evidence has been released about it. This case report demonstrates and discusses the benefit of non-invasive mechanical ventilation in volume-assured pressure support (AVAPS) mode plus pirfenidone based on the relief of apatient'ssymptoms in combination with high-resolution computed tomography (HRCT) evidence.

Material And Methods: An 83-year-old female patient with multiple hospital admissions within a six-month period initially presented with cardiac symptoms which were later attributed to apossible exacerbation of her primary diagnosis, idiopathic pulmonary fibrosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0077DOI Listing
January 2020

Acute eosinophilic pneumonia associated with non-cigarette smoking products: a systematic review.

Authors:
Toufic Chaaban

Adv Respir Med 2020 ;88(2):142-146

Ohio State University Wexner Medical Center, Columbus, United States.

Acute eosinophilic pneumonia (AEP) is characterized by an acute onset respiratory illness with bilateral chest infiltrates and evidence of pulmonary eosinophilia. Cigarette smoking is the main risk factor, but drugs and other inhalational exposures have also been reported. Herein, the association between AEP and smoking devices other than cigarettes is reviewed The PubMed database was searched using terms such as "smoking", "vaping", "e-cigarette", "waterpipe", and "marijuana", along with other commonly used synonyms for these terms. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0088DOI Listing
January 2020

Posterior Mediastinal Paravertebral Müllerian cyst (cyst of Hattori): literature review.

Adv Respir Med 2020 ;88(2):134-141

Department of Cardiothoracic Surgery, Basildon and Thurrock University Hospital, Nethermayne, Basildon, Essex, United Kingdom.

Mediastinal cysts are typically of bronchogenic, thymic or neurenteric origin, but may also represent oesophageal duplication. Posterior paravertebral mediastinal Müllerian cysts of undetermined pathogenesis are very rare occurrences. The first case of a ciliated cyst arising in the mediastinum, of probable Müllerian origin, was reported by Hattori in 2005, which gave rise to the name cyst of Hatorri (COH) The number of reported cases in literature of a similar nature have since then increased significantly. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0089DOI Listing
January 2020

Prevalence of inducible laryngeal obstruction among patients diagnosed as bronchial asthma.

Adv Respir Med 2020 ;88(2):129-133

Mansoura University Egypt, Mansoura, Egypt.

Introduction: Inducible laryngeal obstruction (ILO) is an important cause of a variety of respiratory symptoms and can mimic bronchial asthma (BA). This study was planned to measure the prevalence of ILO among patients diagnosed with BA and to detect its effect on BA control and severity.

Material And Methods: Patients aged 18 years or older who were previously diagnosed with BA were enrolled. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0087DOI Listing
January 2020

Transbronchial lung cryobiopsy guided by radial mini-probe endobronchial ultrasound in interstitial lung diseases - a multicenter prospective study.

Adv Respir Med 2020 ;88(2):123-128

Endoscopy Unit, Pulmonary Hospital, Zakopane, Polan.

Introduction: Transbronchial lung cryobiopsy (TBLC) is commonly used in diagnosing interstitial lung diseases (ILDs). Ageneral anesthesia with endotracheal intubation, balloon blockers and fluoroscopy control is the most common modality. Simplifying the procedure without decreasing it's safety could result in wider use. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0086DOI Listing
January 2020

The -463G/A and -129G/A myeloperoxidase-encoding gene polymorphism in chronic obstructive pulmonary disease.

Adv Respir Med 2020 ;88(2):116-122

Department of Clinical Pharmacology, 1st Chair of Internal Medicine, Medical University of Łódź, Łódź, Poland.

Introduction: Neutrophils are involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). Myeloperoxidase is an important bactericidal granulocytic enzyme. It is of interest to question whether or not the polymorphic variants of the myeloperoxidase-encoding gene are associated with the risk of developing COPD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0085DOI Listing
January 2020

Lung density in the trajectory path is a strong indicator of patients sustaining a pneumothorax during CT-guided lung biopsy.

Adv Respir Med 2020 ;88(2):108-115

Department of Diagnostic Radiology, American University of Beirut, Beirut, Lebanon.

Introduction: The purpose is to evaluate the prognostic significance of lung parenchymal density during percutaneous coaxial cutting needle lung biopsy (PNLB).

Materials And Methods: Retrospective analysis of 179 consecutive patients (106 males, 73 females; mean age 59.16 ± 16. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0084DOI Listing
January 2020

The effects of mold sensitivity on the clinical characteristics of adult asthmatic patients.

Adv Respir Med 2020 ;88(2):99-107

Recep Tayyip Erdoğan University School of Medicine, Rize, Turkey.

Introduction: The effects of mold sensitivity on the development and course of asthma have been researched previously, although study results vary. We sought to evaluate the characteristics of our mold-sensitive patients in comparison with those of other adult asthmatic patients.

Materials And Methods: Data were collected retrospectively from adult asthmatic patients who underwent regular follow-ups at our tertiary care outpatient clinic for immunology and allergic diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0083DOI Listing
January 2020

New spirometry? The 2019 update of the test standardization.

Adv Respir Med 2020 ;88(2):95-98

3rd Lung Diseases and Oncology Department, National T uberculosis and Lung Diseases R esearch Institute, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0082DOI Listing
January 2020

Coronavirus - preventing an occupational hazard among doctors.

Adv Respir Med 2020 20;88(2):166-168. Epub 2020 Apr 20.

Department of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.a2020.0096DOI Listing

Guidelines of the Polish Respiratory Society for diagnosis and treatment of idiopathic pulmonary fibrosis.

Adv Respir Med 2020 ;88(1):41-93

First Lung Diseases Department, National Tuberculosis and Lung Diseases Research Institute in Warsaw, Poland.

Introduction: This document presents the guidelines of the Polish Respiratory Society (PTChP, Polskie Towarzystwo Chorób Płuc) for diagnosis and treatment of idiopathic pulmonary fibrosis (IPF), developed by agroup of Polish experts.

Material And Methods: The recommendations were developed in the form of answers to previously formulated questions concer-ning everyday diagnostic and therapeutic challenges. They were developed based on acurrent literature review using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0081DOI Listing
January 2020

COPD 2020 Guidelines - what is new and why?

Adv Respir Med 2020;88(1):38-40

Department of Pulmonary, Critical Care and Sleep Medicine, VMMC and Safdarjung Hospital, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0080DOI Listing
January 2020

Defying the paradigm - rescue thrombolysis in a postoperative patient with pulmonary embolism.

Adv Respir Med 2020 ;88(1):36-37

All India Institute of Medical Sciences, Jodhpur, India.

Parenteral anticoagulation is recommended for patients of intermediate - high early mortality risk pulmonary embolism. Rescue reperfusion is considered if signs of hemodynamic decompensation appear. Recent surgery is a contraindication to thrombolysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0079DOI Listing
January 2020

Hemoptysis with lung cavity - triple whammy.

Adv Respir Med 2020;88(1):34-35

VMMC and Safdarjung Hospital, New Delhi, India, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.a2020.0078DOI Listing
January 2020

Double or nothing: old chest X-ray as a clue to lung mass.

Adv Respir Med 2020 ;88(1):30-33

Division of Pulmonary, Critical Care and Sleep Medicine, Westchester Medical Center, Valhalla, New York, United States.

Mucoepidermoid carcinoma is ayoung person's lung cancer with no apparent causal connection to smoking. It exhibits slow growth, which can make it challenging to detect changes in size on serial chest imaging. Another way of describing its growth pattern is that mucoepidermoid carcinoma has an unusually long volume doubling time. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0076DOI Listing
January 2020

Treatment of persistent air leak with endobronchial valves.

Adv Respir Med 2020 ;88(1):27-29

Department of Respiratory Diseases, AZ Delta Roeselare, Roeselare, Belgium.

Persistent pulmonary air leaks are usually treated conservatively with prolonged thoracostomy tube drainage. In case this approach fails, surgical revision used to be the only option. This case report describes the successful treatment of a 66-year old patient who developped a pulmonary air leak after cardiothoracic surgery that persisted despite attempted surgical repair and talc pleurodesis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.a2020.0075DOI Listing
January 2020

Imaging methods for pulmonary sarcoidosis.

Adv Respir Med 2020 ;88(1):18-26

Department of Lung Diseases and Tuberculosis, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland.

Sarcoidosis is achronic systemic granulomatous disease of unknown etiology. In more than 90% of patients with diagnosed sarcoidosis, mediastinal and hilar lymph nodes are affected. The objective of this paper is to discuss the most important chest imaging methods in pulmonary sarcoidosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0074DOI Listing
January 2020

Extracorporeal life support after failure of thrombolysis in pulmonary embolism.

Adv Respir Med 2020 ;88(1):13-17

Medical Campus University of Oldenburg, European Medical School, Department of Internal Medicine and Intensive Care Medicine, Evangelisches Krankenhaus Oldenburg, Oldenburg, Germany.

Introduction: Fulminant pulmonary embolism (PE) may lead to cardiogenic shock or cardiac arrest with high mortality rates (65%) despite treatment with thrombolysis. Patients not responding to this therapy might benefit from extracorporeal life support (ECLS). Only occasional case reports of ECLS in PE patients are available. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.a2020.0073DOI Listing
January 2020

Screening diabetes mellitus patients for tuberculosis in Southern Nigeria: A pilot study.

Adv Respir Med 2020 ;88(1):6-12

German Leprosy and TB Relief Association, Nigeria.

Introduction: Diabetes mellitus (DM) and tuberculosis (TB) are of great public health importance globally, especially in Sub-Saharan Africa. Tuberculosis is the third cause of death among subjects with non-communicable diseases. DM increases risk of progressing from latent to active tuberculosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0072DOI Listing
January 2020

Differences in right ventricular dysfunction in patients with idiopathic pulmonary hypertension versus secondary pulmonary hypertension.

Adv Respir Med 2020 ;88(1):1-5

Department of Medicine, University of Arizona, Tucson, Arizona.

Introduction: Right ventricular (RV) function in the setting of pulmonary hypertension based on different etiologies has not been well studied. In this study, we evaluated the RV function in patients with idiopathic pulmonary hypertension (IPH) versus secon-dary pulmonary hypertension (SPH) due to congestive heart failure.

Material And Method: Forty-five patients with pulmonary hypertension and New York Heart Association (NYHA) functional class II or III were enrolled. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2020.0071DOI Listing
January 2020

Should I stay or should I go? Pulmonary embolism and air travel.

Adv Respir Med 2019 ;87(6):277

Department of Respiratory Medicine, University of Thessaly, School of Medicine, General Hospital of Larisa, Larisa, Greece.

Many respiratory conditions can affect a passenger's fitness to fly with pulmonary embolism being the most debatable. A major question that respiratory physicians frequently have to answer, mostly with visitors from overseas who need to be repatriated following diagnosis of pulmonary embolism, is about the right time to "fly with a clot". Risk of flying after being diagnosed with pulmonary embolism is not the same for all patients and in every case we should take into consideration the risk stratification on presentation and the PaO2 level. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0070DOI Listing
January 2019

Integrating multi-disciplinary discussion in clinical practice.

Adv Respir Med 2019 ;87(6):274-276

Hematology Department, Metaxa Hospital, Athens, Greece.

Interstitial lung diseases are very heterogeneous. We present a case of usual interstitial pneumonia pattern on high resolution computed tomography of the chest that was diagnosed successfully after multi-disciplinary discussion. Pulmonologists should be aware of the pitfalls in the diagnostic management of interstitial lung diseases, especially in cases with atypical clinical presentation and systemic signs and symptoms. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0069DOI Listing
January 2019

Isolated persistent left superior vena cava in a young adult without cardiac disease.

Adv Respir Med 2019;87(6):272-273

All India Institute of Medical Sciences, Bhubaneswar, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0068DOI Listing
January 2019

An uncommon cause of hemoptysis in pulmonary tuberculosis.

Adv Respir Med 2019;87(6):270-271

VMMC and Safdarjung Hospital, New Delhi, India, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0067DOI Listing
January 2019

Cystic lung disease in an adult non-smoker.

Adv Respir Med 2019 ;87(6):268-269

VMMC and Safdarjung Hospital, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0066DOI Listing
January 2019

Not everything is what it seems: malignant pleural mesothelioma mimicking lung cancer.

Adv Respir Med 2019 ;87(6):265-267

Division of Thoracic Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Malignant pleural mesothelioma usually arises from the pleural surface and progressively encases the lungs. Pulmonary involvement generally occurs at an advanced stage, while intraparenchymal nodules, in the absence of pleural lesions, constitute a less frequent presentation. We describe the case of a patient with multiple bilateral pulmonary nodules, mediastinal lymphadenopathies and left pleural effusion in the absence of pleural lesions, simulating advanced stage lung cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0065DOI Listing
January 2019

Difficulties in recognizing granulomatosis with polyangiitis (GPA) in elderly patients undergoing diagnostic thoracotomy twice - a report of two cases.

Adv Respir Med 2019 ;87(6):258-264

Third Department of Pneumonology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.

Granulomatosis with polyangiitis (GPA) is defined as a necrotizing granulomatous inflammation usually involving the upper and lower respiratory tract with necrotizing vasculitis affecting predominantly small to medium vessels. Because of non-specific symptoms, its radiological presentation, and the diversity of its clinical expression, it is not uncommon to for it to be misdiagnosed, especially in the elderly. Although biopsy and histological examination seem to be essential for GPA diagnosis, their results are sometimes ambiguous and not helpful in making a decision. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0064DOI Listing
January 2019

Exogenous lipoid pneumonia induced by nasal instillation of paraffin oil.

Adv Respir Med 2019 ;87(6):254-257

Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.

Lipoid pneumonia is a rare pulmonary disease, classified in terms of the source of lipid exposure into two variants: exogenous and endogenous. We present a patient with exogenous lipoid pneumonia, acquired after chronic exposure to paraffin oil-containing nasal drops. The diagnosis was established by demonstration of lipid-laden macrophages in bronchoalveolar lavage, chest computed tomography results and a history of lipid exposure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0063DOI Listing
January 2019

Atypical manifestations of granulomatosis with polyangiitis: the diagnostic challenge for pulmonologists.

Adv Respir Med 2019 ;87(6):244-253

Department of Allergology, Medical University of Gdańsk, Gdańsk, Poland.

This is a review considering atypical manifestations of granulomatosis with polyangiitis (GPA). Virtually any organ can be affected, and in some patients, GPA can manifest unusually. Since thoracic involvement of GPA often predominates, the first who might be expected to establish a diagnosis are pulmonary specialists. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0062DOI Listing
January 2019

Advances in the diagnosis and management of pulmonary aspergillosis.

Adv Respir Med 2019 ;87(6):231-243

Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, USA.

Aspergillus is a mould that is ubiquitous in nature and may lead to a variety of infectious and allergic diseases depending on the host's immune status or pulmonary structure. Invasive pulmonaryaspergillosisoccurs primarily in patients with severe immunodeficiency. The significance of this infection has dramatically increased with growing numbers of patients with impaired immune state associated with the management of malignancy, organ transplantation, autoimmune and inflammatory conditions; critically ill patients appear to be at an increased risk as well. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0061DOI Listing
January 2019

Diagnostic and treatment standards in idiopathic pulmonary fibrosis in the era of antifibrotic drugs in Poland: A real-world practice survey.

Adv Respir Med 2019 ;87(6):221-230

Department of Pneumology and Allergy, Medical University of Lodz, Lodz, Poland.

Background Currently, only two drugs have been shown to modify the inevitable natural history of idiopathic pulmonary fibrosis (IPF). Changes in the reimbursement policy for antifibrotic drugs in Poland have led to the availability of pirfenidone from January 2017 and nintedanib from March 2018 for the treatment of Polish patients with IPF. This study aimed to evaluate the possible changes and shortcomings in the clinical practice standards in IPF in the era of access to antifibrotic therapy in Poland. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0060DOI Listing
January 2019

Does bronchiectasis affect COPD comorbidities?

Adv Respir Med 2019 ;87(6):214-220

Second Department of Respiratory Medicine, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.

Introduction: COPD and bronchiectasis, chronic inflammation disorders of the bronchial tree through the mechanism of 'spill-over' of inflammatory mediators, may lead to systemic manifestations of illness of the respiratory system and comorbidities. The aim of the study was to evaluate the frequency of coexisting chronic obstructive pulmonary disease and bronchiectasis and influence of bronchiectasis on COPD comorbid diseases.

Material And Methods: A post-hoc cross-sectional analysis of cohort study of 288 consecutive patients hospitalized due to acute exacerbation of COPD was performed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0059DOI Listing
January 2019

Social networks and traditional metrics of impact in pulmonary medicine journals: a correlation study.

Adv Respir Med 2019 ;87(6):209-213

Internal Medicine Department, Hospital Universitario San Ignacio, Bogota, Colombia.

Introduction: The Scimago Journal Rank (SJR) impact factor is extensively used. However, as the Internet has become widely available, new metrics are coming into play. Our research aims to determine whether a correlation between the SJR impact factor and metrics reflecting social media activity does exist. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0058DOI Listing
January 2019

Relationship between CHA2DS2-VASc and CHADS2 scores with pulmonary hypertension in patients with acute pulmonary embolism.

Adv Respir Med 2019 ;87(6):203-208

Saglik Bilimleri Universitesi Bilkent Şehir Hastanesi, Ankara, Turkey.

Introduction: Pulmonary hypertension (PH) is the most important prognostic factor after acute pulmonary embolism (PE). Therefore, determination of patients who will develop PH after acute PE is crucial. The aim of the present study was to evaluate the predictive value of the CHADS2 and CHA2DS2-VASc scores for PH in patients with acute PE. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0057DOI Listing
January 2019

Acute subglottic laryngitis. Etiology, epidemiology, pathogenesis and clinical picture.

Adv Respir Med 2019 ;87(5):308-316

Department of Otolaryngology, Children's Hospital, Warsaw, Poland.

In about 3% of children, viral infections of the airways that develop in early childhood lead to narrowing of the laryngeal lumen in the subglottic region resulting in symptoms such as hoarseness, abarking cough, stridor, and dyspnea. These infections may eventually cause respiratory failure. The disease is often called acute subglottic laryngitis (ASL). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0056DOI Listing
April 2020
1 Read

An expectorated hydatid.

Adv Respir Med 2019;87(5):307

Calcutta National Medical College and Hospital, Kolkata, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0055DOI Listing

A late presentation of an uncommon congenital vascular anomaly.

Adv Respir Med 2019;87(5):305-306

Department of Pulmonary Critical Care And Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0054DOI Listing

Oligo-recurrence from anaplastic lymphoma kinase-rearranged lung adenocarcinoma.

Adv Respir Med 2019 ;87(5):301-304

Mito Medical Center, University of Tsukuba, Miya-machi, Mito, Japan.

Anaplastic lymphoma kinase rearranged non-small-cell lung cancer is arare disease. Among them, asubset of patients exist who exhibit relatively slowly progressing symptoms and have oligo-metastases. In this article, we present two cases of ALK rearran-ged lung adenocarcinoma in patients who experienced postoperative oligo-recurrence. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0053DOI Listing
April 2020
1 Read

Neurogenic pulmonary oedema as a rare complication of epileptic seizures.

Adv Respir Med 2019 ;87(5):298-300

Department of Respiratory Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Czech Republic.

Introduction: Neurogenic pulmonary oedema (NPE) is avery rare complication of epileptic seizures, which could potentially increase mortality.

Material And Methods: The case of a66-year-old male patient with NPE caused by repeated epileptic seizures is reported. Rapid resolution of pulmonary oedema is well documented by X-ray and computed tomography images. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0052DOI Listing

Current treatment strategies in malignant pleural mesothelioma with a treatment algorithm.

Adv Respir Med 2019 ;87(5):289-297

Department of Radiation Oncology, Mehmet Ali Aydınlar Acıbadem University, School of Medicine, Istanbul, Turkey.

Malignant pleural mesothelioma (MPM) is arare disease with apoor prognosis. The main therapeutic options for MPM include surgery, chemotherapy, and radiation therapy (RT). Although multimodality therapy has been reported to improve survival, not every medically operable patient is able to undergo all recommended therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0051DOI Listing

Sputum culture for the diagnosis of tuberculous pleural effusion: analysis of absolute and incremental yields.

Adv Respir Med 2019 ;87(5):281-288

Division of Pulmonary, Critical Care and Sleep Medicine, Westchester Medical Center, Valhalla, NY, USA.

Introduction: Pleural fluid culture yield in tuberculous pleural effusion (TPE) is disappointing in immunocompetent hosts. Herein, we attempt to define the role of serial sputum cultures in the diagnosis of TPE.

Material And Methods: We identified cases diagnosed with TPE over a16-year period in ahigh-prevalence US hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0050DOI Listing

The role of genexpert in the diagnosis of tubercular pleural effusion in India.

Adv Respir Med 2019 ;87(5):276-280

Department of Pulmonary Medicine, SDS TRC and Rajiv Gandhi Institute of Chest Medicine, Someshwaranagara, Bengaluru, India.

Introduction: Tubercular pleural effusion is the second most common extrapulmonary form of tuberculosis in India. Developing nations like India face several health challenges and with limited resources, appropriate planning and channelization of the same is the need of the hour.

Material And Methods: The objective of the study was to determine the role of cartridge-based nucleic acid amplification test (CBNAAT) in the diagnosis of tubercular pleural effusion (TPE) and also to study if any association exists between CBNAAT and pleural fluid adenosine deaminase (ADA) and lymphocyte counts. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0049DOI Listing

Diagnostic values of bronchodilator response versus 9-question questionnaire for asthma.

Adv Respir Med 2019 ;87(5):269-275

Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Introduction: Several studies have investigated different tools for asthma diagnosis in order to reduce the cost and improve its early recognition. The goal of this study is to establish ashort questionnaire to be used in practice for asthma screening and compare diagnostic values between this method and spirometric response to bronchodilators.

Material And Method: 208 patients presenting with chronic stable dyspnea (> 6 months) and definite clinical diagnosis of chronic obstructive pulmonary disease, bronchiectasis, pulmonary fibrosis or asthma, were enrolled. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0048DOI Listing
April 2020
1 Read

Effect of yoga on FEV1, 6-minute walk distance (6-MWD) and quality of life in patients with COPD group B.

Adv Respir Med 2019 ;87(5):261-268

Pulmonology and Respiratory Medicine, Faculty of Medicine, Tadulako University, Tadulako Hospital Palu, Palu, Indonesia.

Introduction: Yoga is used in the treatment of various diseases, including chronic obstructive pulmonary disease. However, no studies have assessed the effect of yoga on COPD patients in Indonesia. The difference between this study and similar studies completed in other countries lies in the type of yoga exercises completed, the method in which they were completed, and in certain, unique demographic characteristics. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/ARM.2019.0047DOI Listing